Claim Missing Document
Check
Articles

Found 22 Documents
Search

Supervisi Pencegahan dan Pengobatan ISPA melalui Konsultasi: Edukasi Konsumen di Apotek X Elmira Yulian Yori; Nurul Fajri; Lili Musnelina; Putu Rika Veryanti; Teodhora, Teodhora; Vilya Syafriana; Jenny Pontoan; Teti Indrawati; Munawarohthus Sholikha; Ika Maruya Kusuma; Siswati, Siswati; Herdini, Herdini; Vina Novia
Jurnal Kepengawasan, Supervisi dan Manajerial (JKSM) Vol. 4 No. 1 (2026): Februari
Publisher : Perkumpulan Cendekia Muda Kreatif Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61116/jksm.v4i1.907

Abstract

Infeksi Saluran Pernapasan Akut (ISPA) merupakan penyebab utama morbiditas dan mortalitas di dunia, dengan angka kematian mencapai 4,25 juta per tahun. Pengetahuan masyarakat tentang ISPA sangat penting dalam pencegahan dan pengobatan penyakit ini. Kegiatan ini bertujuan untuk memberikan edukasi melalui penyebaran leaflet dan pengisian kuesioner kepada konsumen di Apotek X, serta untuk mengevaluasi tingkat pemahaman masyarakat mengenai ISPA. Edukasi dilakukan pada 30 konsumen yang dipilih secara acak antara 14 hingga 27 Desember 2024. Hasilnya menunjukkan bahwa sebagian besar konsumen (98 %) setelah diedukasi memiliki pemahaman yang baik tentang ISPA, gejalanya, serta cara pencegahan dan pengobatannya, baik melalui terapi farmakologi (obat-obatan) maupun non-farmakologi (istirahat dan gizi yang baik). Meskipun demikian, masih ada beberapa konsumen yang perlu lebih memahami detail mengenai jenis ISPA dan penggunaan obat tertentu. Kegiatan ini menyimpulkan bahwa edukasi yang dilakukan berhasil meningkatkan pemahaman masyarakat dan dapat dijadikan sebagai langkah untuk mengurangi prevalensi ISPA di masa depan. Kedepannya, penting untuk terus melakukan edukasi kepada masyarakat agar pengetahuan mengenai ISPA semakin meningkat.
EFFECTIVENESS OF BRONCHODILATOR AND CORTICOSTEROID TREATMENT IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) Putu Rika Veryanti; Ainun Wulandari
Journal Pharmaceutical Science and Application Vol. 2 No. 1 (2020): Journal Pharmaceutical Science and Application (JPSA)
Publisher : Pharmacy Department, Math and Sciences Faculty, Udayana Univerity

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24843/JPSA.2020.v02.i01.p03

Abstract

Background: Chronic Obstructive Pulmonary Disease (COPD) is a chronic airway disease which is characterized by progressive airway obstruction. Bronchodilators and corticosteroids are the first choices of therapy in COPD patients. The goal therapy of COPD patients is to prevent respiratory failure, which can impact on death. But nowadays, the mortality rate due to COPD continues to increase. WHO predicts mortality from COPD in the year 2030 will be ranked third in the world. This high mortality can be caused by the ineffectiveness of therapy given. Objective: The aim of this study is to find out the effectiveness of bronchodilator and corticosteroid treatments in COPD patients. Methods: An observational study conducted retrospectively in the 2018 period at Fatmawati Central General Hospital. The effectiveness of therapy was assessed from the patient's clinical condition, blood gas values (PaO2 & PaCO2) and the average length of stay (AvLOS). Results: COPD was mostly suffered by males (83,33%), and the highest age for COPD was in the range of 45 years and above (90%). Bronchodilator that commonly prescribed were albuterol (30.08%), ipratropium bromide (12.2%), fenoterol hydrobromide (10.57%), terbutaline sulfate (8.13%), theophylline (1.63%) and aminophylline (5.69%), while the corticosteroids were budesonide (17.07%), methylprednisolone (9.76%) and dexamethasone (4.88%). Bronchodilator and corticosteroid had improved patient's clinical condition (96.67% patients) and also improved PaO2 & PaCO2 values patients. There was a significant improvement in PaO2 and PaCO2 value in COPD patients (p <0.05). Conclusion: Bronchodilator and corticosteroid in COPD patients had improved patient's clinical condition and PaO2 & PaCO2 values, but the average length of stay exceeds the standard (6-9 days). Keywords: Bronchodilator; Corticosteroid; COPD; Blood Gas Analysis; Average Length of Stay